14.3 Seminal Fluid and Amniotic Fluid Analysis

Seminal Fluid and Amniotic Fluid Analysis

Seminal fluid (8%) and amniotic fluid (2%) are tested within the Clinical Microscopy blueprint. Semen analysis evaluates male fertility and the success of vasectomy and supports forensic work. Amniotic fluid analysis assesses fetal lung maturity, hemolytic disease, and neural tube defects. Both depend on strict collection and handling rules and on reference limits that changed with the WHO 6th edition (2021) semen manual. Fecal analysis and gastric, duodenal, and respiratory specimens are covered in the next two sections.

---

1. Seminal Fluid Analysis (WHO 6th Edition Standards)

Seminal fluid (semen) is a complex suspension of spermatozoa suspended in seminal plasma produced sequentially by four distinct anatomical glands of the male reproductive tract.

Glandular Contributions to the Ejaculate

1. Testes and Epididymides (2% to 5% of total volume): The seminiferous tubules produce spermatozoa under the influence of follicle-stimulating hormone (FSH) and testosterone. Spermatozoa mature, acquire progressive motility, and are stored within the epididymis over a 10 to 14 day transit.
2. Seminal Vesicles (60% to 70% of total volume): Paired glands that secrete a viscous, yellowish, alkaline fluid rich in fructose (the primary metabolic energy substrate for sperm motility), flavins (responsible for sperm fluorescence under ultraviolet light in forensic investigations), and semenogelin I and II (fibrinogen-like coagulating proteins that form the initial gelatinous seminal coagulum).
3. Prostate Gland (20% to 30% of total volume): Secretes a milky, slightly acidic fluid (pH ≈ 6.5) containing high concentrations of citric acid, zinc, magnesium, acid phosphatase, and proteolytic enzymes—including prostate-specific antigen (PSA), a serine protease that hydrolyzes semenogelins to liquefy the coagulated semen within 30 to 60 minutes.
4. Bulbourethral (Cowper's) and Periurethral (Littre) Glands (< 5% of total volume): Produce clear, highly alkaline, mucoid secretions immediately prior to ejaculation that neutralize residual acidic urine in the penile urethra.

Pre-Analytical Requirements and Specimen Collection

• Period of Sexual Abstinence: Strictly 2 to 7 days. Abstinence < 2 days produces falsely low semen volume and sperm count; abstinence > 7 days increases sperm count but decreases motility and increases senescence/morphological anomalies.
• Collection Technique: Collected by masturbation directly into a sterile, non-toxic, wide-mouthed plastic or glass container. Ordinary latex condoms containing spermicides (nonoxynol-9) must never be used.
• Delivery and Temperature: Delivered to the laboratory within 1 hour of collection, maintained at ambient or body temperature (20 to 37°C).
• Completeness of Collection: The initial portion of the ejaculate contains the highest concentration of spermatozoa and prostatic secretions; the terminal portion contains seminal vesicle fluid. Loss of the first portion falsely depresses sperm count, while loss of the terminal portion impairs coagulation and reduces volume.

Macroscopic Examination

• Liquefaction: Fresh semen forms a firm coagulum that must liquefy into a homogenous liquid within 30 to 60 minutes at room temperature. Delayed or incomplete liquefaction (> 60 minutes) indicates prostatic deficiency (lack of proteolytic enzymes/PSA).
• Viscosity: Assessed following complete liquefaction by drawing fluid into a pipette and observing drop formation. Normal semen falls in discrete, watery drops. High viscosity is present if droplets form a persistent thread or strand > 2.0 cm.
• Volume: Normal volume is ≥ 1.4 mL (WHO 6th Edition, 2021; previously 1.5 mL in WHO 5th Edition). Volume < 1.4 mL (hypospermia) suggests retrograde ejaculation, incomplete collection, or ejaculatory duct obstruction.
• Appearance: Normal semen is translucent, gray-white, and opalescent. Red-brown discoloration indicates hematospermia (erythrocytes); yellow discoloration indicates flavin accumulation, jaundice, or urine contamination; dense turbidity indicates pyospermia.
• pH: Measured within 1 hour using narrow-range pH paper. Normal: ≥ 7.2 (typically 7.2 to 8.0). An acidic pH < 7.0 in an azoospermic specimen indicates bilateral seminal vesicle agenesis or complete ejaculatory duct obstruction.

Microscopic Examination

                                  ┌─ Sperm Concentration ──► ≥ 16 × 10^6 sperm/mL (Total: ≥ 39 × 10^6) 
                                  │
Microscopic Semen Evaluation ─────┼─ Sperm Motility ───────► Progressive (PR) ≥ 30%, Total (PR+NP) ≥ 42%
(WHO 6th Edition Standards)       │
                                  ├─ Sperm Morphology ─────► Normal Forms ≥ 4.0% (Kruger Strict Criteria)
                                  │
                                  └─ Sperm Vitality ───────► Viable (Unstained) ≥ 54% (Eosin-Nigrosin)

• Sperm Concentration and Total Sperm Count: Determined via Improved Neubauer hemocytometer using a 1:20 dilution in an immobilizing solution (5% NaHCO3 and 1% formalin):
  • Normal Concentration: ≥ 16 × 10^6 spermatozoa/mL.
  • Normal Total Count per Ejaculate: ≥ 39 × 10^6 spermatozoa (Volume × Concentration).
  • Terminology: Oligozoospermia (< 16 × 10^6/mL); Azoospermia (complete absence of sperm in native and centrifuged sediment); Aspermia (complete absence of ejaculate).
• Motility: Evaluated at 37°C on a wet prep within 60 minutes, grading at least 200 sperm. The WHO 6th edition (2021) restored four grades:
  • Rapidly Progressive (grade a): Moving actively forward at $\ge 25\ \mu\text{m/s}$.
  • Slowly Progressive (grade b): Moving forward at $5\text{ to }< 25\ \mu\text{m/s}$.
  • Non-progressive (grade c): Movement without forward progression ($< 5\ \mu\text{m/s}$), such as small circles or flagellar flagging.
  • Immotile (grade d): No movement.
  • Reference Limits: Total motility (a + b + c) ≥ 42% and progressive motility (a + b) ≥ 30%. (The WHO 5th edition used three grades with limits of 40% total and 32% progressive.) Asthenozoospermia denotes motility below threshold.
• Morphology (Kruger Strict Criteria): Evaluated on air-dried, fixed smears stained with Papanicolaou or Giemsa. Normal sperm features a smooth oval head (4.0 to 5.0 µm length, 2.5 to 3.5 µm width), an acrosome covering 40% to 70% of the head, a slender midpiece (6 to 8 µm), and an uncoiled tail (40 to 50 µm). Normal morphology threshold: ≥ 4.0% normal oval forms. Teratozoospermia denotes < 4% normal forms.
• Sperm Vitality / Viability (Eosin-Nigrosin Dye Exclusion): Indicated whenever progressive motility is < 40%. Living sperm possess intact cell membranes that exclude eosin dye, appearing white (unstained) against a dark nigrosin background. Non-viable (dead) sperm have disrupted membranes that absorb eosin, appearing pink or red.
  • Normal Threshold: ≥ 54% viable spermatozoa (WHO 6th edition; 58% in the 5th edition).
  • Clinical Significance: Distinguishes true necrozoospermia (dead sperm taking up red stain) from living immotile sperm (white unstained viable sperm with axonemal dynein arm deficiencies, as in Kartagener syndrome / Primary Ciliary Dyskinesia).
• Round Cells: Normal ejaculate contains < 1.0 × 10^6 round cells/mL. A myeloperoxidase stain differentiates peroxidase-positive leukocytes from peroxidase-negative immature spermatids (leukocytospermia is defined as > 1.0 × 10^6 WBCs/mL, indicating genital tract infection).

Chemical Markers in Seminal Plasma

• Fructose (Resorcinol Test): Boiling semen with resorcinol and concentrated hydrochloric acid produces an orange-red precipitate in the presence of fructose. Absence confirms seminal vesicle agenesis or ejaculatory duct obstruction.
• Acid Phosphatase and PSA: Extremely concentrated in prostatic fluid; utilized in forensic medicine to confirm suspected semen in sexual assault investigations.

---

2. Amniotic Fluid Analysis

Amniotic fluid cushions the developing fetus, maintains constant intrauterine temperature, facilitates musculoskeletal development, and provides metabolic waste clearance. Collected via transabdominal amniocentesis under real-time ultrasound guidance.

Differentiation from Maternal Urine

Accidental bladder puncture during amniocentesis must be ruled out immediately:

• Amniotic Fluid: Protein positive, glucose positive, low urea nitrogen (< 30 mg/dL), low creatinine (< 3.5 mg/dL, typically 1.5 to 2.0 mg/dL). Shows ferning (arborization) upon air-drying on a glass slide due to protein-electrolyte crystallization.
• Maternal Urine: Protein negative, glucose negative, high urea nitrogen (> 300 mg/dL), and very high creatinine (> 10 mg/dL, typically 30 to 100 mg/dL). Fern test is negative.

Fetal Lung Maturity (FLM) Testing

Neonatal Respiratory Distress Syndrome (RDS) results from insufficient surfactant production by alveolar type II pneumocytes, causing alveolar collapse at expiration.

1. Lecithin-to-Sphingomyelin (L/S) Ratio: Analyzed via thin-layer chromatography (TLC). Lecithin (dipalmitoylphosphatidylcholine) is the primary alveolar surfactant that rises sharply around week 35 of gestation. Sphingomyelin serves as an internal control, remaining constant.
   • L/S Ratio ≥ 2.0: Confirms fetal pulmonary maturity (minimal risk of neonatal RDS upon delivery).
   • L/S Ratio < 1.5: Severe pulmonary immaturity (high risk of neonatal RDS).
2. Phosphatidylglycerol (PG): An essential minor phospholipid surfactant that appears at 35–36 weeks. Evaluated by slide agglutination (Amniostat-FLM). PG is NOT affected by blood or meconium contamination, which falsely elevates the L/S ratio. PG testing is critical in diabetic pregnancies where surfactant maturation is delayed.
3. Lamellar Body Count (LBC): Lamellar bodies are layered phospholipid storage packets of surfactant secreted into alveolar spaces. Because lamellar bodies have a particle volume (about 1.7 to 7.3 fL) that overlaps the platelet size window, they are enumerated directly on the platelet channel of automated hematology cell counters without centrifugation.
   • LBC ≥ 50,000/µL: Definitively confirms fetal lung maturity.
   • LBC < 15,000/µL: Indicates pulmonary immaturity.
4. Foam Stability Index (Shake Test): Equal parts 95% ethanol and amniotic fluid are shaken vigorously for 15 seconds. Persistence of a continuous ring of bubbles at the meniscus after 15 minutes indicates surfactant sufficiency.

Hemolytic Disease of the Fetus and Newborn (Erythroblastosis Fetalis)

Fetal erythrocyte destruction mediated by maternal Rh (anti-D) alloantibodies produces unconjugated bilirubin that accumulates in amniotic fluid. Spectrophotometric absorbance is measured across 350 to 700 nm. The net absorbance peak at 450 nm (ΔA450) above a baseline drawn from 365 nm to 550 nm is plotted against gestational age on the Liley Three-Zone Graph:

• Zone I (Low Zone): Unaffected or mildly affected fetus; managed conservatively.
• Zone II (Mid Zone): Moderate hemolysis; requires serial amniocentesis.
• Zone III (High Zone): Severe fetal hemolysis with impending intrauterine fetal demise; mandates immediate intrauterine blood transfusion or emergent delivery.

Neural Tube Defects (NTD)

• Alpha-Fetoprotein (AFP): Major fetal serum glycoprotein. Markedly elevated in amniotic fluid and maternal serum in open neural tube defects (anencephaly, spina bifida) and abdominal wall defects (gastroschisis, omphalocele).
• Acetylcholinesterase (AChE): Confirmatory testing performed via polyacrylamide gel electrophoresis; presence of an AChE band confirms open neural tube exposure (neural tissue contains acetylcholinesterase, which is absent in non-neural causes of elevated AFP).

---

3. Summary Reference Tables

Semen Analysis Reference Standards (WHO 6th Edition, 2021)

Seminal and Amniotic Fluid Diagnostic Summary Matrix